The incidence of lung cancer in females is increasing, in contrast to that seen in males. In addition, the proportion of lung cancer cases in women attributable to smoking is approximately half of that seen in males. Female sex hormones, especially estrogen, may play a key role in this. Estrogen receptors ERα and ER have been detected on lung cancer cells and there is new evidence suggesting that hormone-replacement therapy may increase both the incidence of, and mortality from, lung cancer in women. Laboratory evidence lends credence to the carcinogenic effects of estrogens in lung cancer. This article summarizes the current evidence on their role in lung cancer.

Original languageEnglish (US)
Pages (from-to)509-518
Number of pages10
JournalExpert Review of Respiratory Medicine
Issue number4
StatePublished - Aug 2010


  • estrogen
  • estrogen receptors
  • fulvestrant
  • hormone-replacement therapy
  • lung cancer
  • women

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health


Dive into the research topics of 'Lung cancer in women: Role of estrogens'. Together they form a unique fingerprint.

Cite this